HSVtk/GCV System on Hepatoma Carcinoma Cells: Construction of the Plasmid pcDNA3.1-pAFP-TK and Targeted Killing Effect

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2017.6657
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Synergistic Effect of Resveratrol and HSV-TK/GCV Therapy on Murine Hepatoma Cells

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

Killing Effect of the Herpes Simplex Virus Thymidine Kinase/Ganciclovir Enzyme/Prodrug System on Human Nasopharyngeal Carcinoma Cells

Journal of International Medical Research
BiochemistryMedicineCell Biology
2007English

Construction of Recombinant Plasmid pcDNA3.1/BMP-2 and Its Involvement in Differentiation of Human Dental Pulp-Derived Cells Into an Odontoblastic Lineage

Makara Journal of Health Research
2010English

Selection of HSV-1 TK Gene-Transfected Murine Mammary Carcinoma Cells Resistant to (E)-5-(2-Bromovinyl)-2′-Deoxyuridine (BVDU) and Ganciclovir (GCV)

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2000English

RETRACTED: Effects of Oxymatrine on the Proliferation and Apoptosis of Human Hepatoma Carcinoma Cells

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2015English

Proteomic Analysis of Bladder Cancer Indicates PRX-I as a Key Molecule in BI-TK/GCV Treatment System

PLoS ONE
Multidisciplinary
2014English

Targeted Killing of Cultured Cells by Receptor-Dependent Photosensitization.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

HSV-tk/GCV Gene Therapy Mediated by EBV-LMP1 for EBV-associated Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2008English

Killing Cancer Cells by Targeted Drug-Carrying Phage Nanomedicines

BMC Biotechnology
Biotechnology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy